Therefore, we determined the levels of the active TGF-β peptide in patients with mild/advanced fibrosis and cirrhosis in an effort to see whether TGF-β is the link between fibrosis and the expression patterns of ANGPTL-3 and ANGPTL-4. This evidence concerns the gene ANGPTL4 and Cirrhosis.